Delhi-based biotech firm Vyome Therapeutics is set to go public in the US through a three-part transaction, including a reverse merger with California-based Reshape Lifesciences, according to statements issued by the...
Ajooni Biotech ties up with Avalon Bioenergy for sustainable moringa processing
Ajooni Biotech said that it has collaborated with Avalon Bioenergy, an Indian subsidiary of the US-based Avalon Energy Group, for sustainable processing of moringa in the country. This collaboration will see the setting...
KKR, Carlyle and EQT among five buyout funds in race for Healthium
Some of the biggest buyout funds KKR, Carlyle, EQT, Hillhouse and TA Associates are competing against each other to buy out Healthium Medtech, the largest homegrown surgical sutures manufacturer, also the largest...
Unitop shareholders drag Rossari Bio to arbitration
The shareholders of Unitop Chemicals started arbitration against promoters of Rossari Biotech, the company which had acquired Unitop in 2021. The Unitop shareholders have alleged that Rossari Biotech has breached the...
Alps Global to go public in US via $1.6 bln blank-check deal
Alps Global Holding Berhad on Wednesday agreed to go public in the U.S. through a merger with a blank-check company in a deal that valued the biotechnology company at $1.6 billion. The proceeds of the deal with special...
NCLAT dismisses PNB’s plea against sale of Sterling Biotech to US-based Perfect Day
The National Company Law Appellate Tribunal has set aside the plea of a UK-based subsidiary of Punjab National Bank against the NCLT order, approving the sale of Sterling Biotech to US-based food technology startup...
Competition Commission of India clears Kotak-Biocon Biologics deal
Fair trade regulator CCI has cleared Kotak Special Situations Fund’s (KSSF) proposed investment in Biocon Biologics Ltd under the green channel route. In February, KSSF, an arm of Kotak Mahindra Bank, announced a...
Biotech firm Tevogen Bio enters $1.2 billion SPAC deal for US listing
Biotech firm Tevogen Bio will go public in the United States through a blank-check merger that values the combined entity at about $1.2 billion, the companies said on Thursday. The deal with Semper Paratus...
Global funds keen to buy fertility chain Indira IVF
About half a dozen global buyout funds have evinced interest in acquiring India’s largest fertility clinic chain Indira IVF, said people aware of the matter. Blackstone, Baring PE Asia EQT, Warburg Pincus, Bain...
Sherlock Bio to buy UK firm in quest for CRISPR-based handheld diagnostic tests
Privately-held Sherlock Biosciences said it has acquired UK-based Sense Biodetection to speed up the launch of handheld diagnostic tests that use the breakthrough CRISPR gene editing technology. Sherlock raised $80...
Quadria Capital eyes Concord Biotech exit
Healthcare-focused private equity fund Quadria Capital will sell its entire 20% stake in active pharmaceutical ingredients (API) maker Concord Biotech in the company’s initial public offering (IPO). Rare Enterprises...
EU antitrust regulators likely to block Illumina, Grail deal – sources
EU antitrust regulators are expected to veto U.S. life sciences firm Illumina’s acquisition of biotechnology company Grail, people familiar with the matter said. There are doubts whether concessions offered by...
